{"id":"W3020695284","doi":"10.1016/j.cell.2020.04.004","title":"Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2","year":2020,"lang":"en","type":"article","venue":"Cell","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":2262,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital; Stemcell Technologies","funders":"H2020 Marie Skłodowska-Curie Actions; European Research Council; Canadian Institutes of Health Research; Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de Cáncer; Fundación Científica Asociación Española Contra el Cáncer","keywords":"Biology; Vero cell; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Angiotensin-converting enzyme 2; Coronavirus; Recombinant DNA; Receptor; Coronavirus disease 2019 (COVID-19); Lung; Organoid; Betacoronavirus; HEK 293 cells; 2019-20 coronavirus outbreak; Virus; Immunology; Gene; Cell biology; Internal medicine; Medicine; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}